Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Decrease in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 1,300 shares, a decrease of 35.0% from the February 13th total of 2,000 shares. Based on an average trading volume of 13,600 shares, the days-to-cover ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group raised Carl Zeiss Meditec from a “sell” rating to a “buy” rating in a research note on Tuesday, March 11th.

Carl Zeiss Meditec Price Performance

OTCMKTS:CZMWY opened at $69.73 on Monday. Carl Zeiss Meditec has a 1-year low of $46.13 and a 1-year high of $133.15. The business’s 50-day moving average price is $57.86 and its two-hundred day moving average price is $61.06.

Carl Zeiss Meditec Announces Dividend

The business also recently announced an annual dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Friday, March 28th will be paid a $0.6246 dividend. This represents a yield of 1%. The ex-dividend date of this dividend is Friday, March 28th. Carl Zeiss Meditec’s payout ratio is 32.64%.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.